Podcast Episode: Open Letter to the DEA: UAMS Doctors Using Controlled Substances for Illegal, No

Pip: There's a question at the heart of this episode that most of us assume medicine already answered: what's the difference between treating a patient and restraining one?

Mara: LauraLynnHammett's recent writing on A Higher Law puts that question in very concrete terms — we're covering a formal complaint to a federal agency, the drugs named in it, and what the record shows about consent, diagnosis, and consequences.

Pip: Let's start with the letter itself.

Open Letter to the DEA: Controlled Substances as Restraint

Mara: The central tension here is a legal and medical one — whether controlled substances administered to a patient without his consent, and without a documented psychiatric diagnosis, constitute treatment or something else entirely.

Pip: The letter lays the allegation out plainly. The setup is a traumatic brain injury, a surgical ICU, and a patient who wanted to leave — and the letter asks: "Were controlled substances prescribed and administered for legitimate medical purposes — or were they used as a means of physically restraining a patient who refused ICU observation of a mild to moderate TBI?"

Mara: That distinction is the spine of the whole complaint. The letter identifies the patient as Sean Lynn, and states that approximately twenty-five UAMS physicians were involved, administering fentanyl, lorazepam, diazepam, Haldol, and other medications beginning January 13, 2024.

Pip: Those aren't incidental medications. And the letter is careful to say the issue isn't whether those drugs have legitimate uses — of course they do — but why they were given to this patient, under whose authority, and for what documented purpose.

Mara: The letter makes a specific evidentiary point: no psychiatrist examined Sean before the restraints began. The justification apparently rested entirely on a mechanism-of-injury report from an EMT who did not witness the accident.

Pip: So the clinical basis for chemically sedating a non-consenting patient was secondhand information from someone who arrived after the fact. That's not a small procedural gap.

Mara: The letter also flags that some medication orders were issued by telephone, without the prescribing physician physically present — which raises additional questions about what information was actually communicated before those orders were placed.

Pip: And the consequences weren't abstract. The letter connects the forced medication to aphasia and hyponatremia, with Sean's sodium falling to approximately 122 — a level the letter describes as extremely serious. Neither condition was documented on arrival.

Mara: Sean remained at UAMS for roughly two weeks against his emphatic protest. The letter notes that his eventual release came against medical advice, and that UAMS subsequently billed more than forty-six thousand dollars. Surveillance video of the incident has reportedly been deleted.

Pip: Which is precisely why the letter asks for an independent investigation rather than asking the DEA to accept any particular interpretation.

Mara: The request to the DEA is specific: examine which controlled substances were prescribed and administered, who ordered and administered each one, whether Sean consented, whether any physician documented an imminent danger, whether a qualified professional evaluated him beforehand, and whether the records accurately reflect what occurred.

Pip: The closing question in the letter is the simplest version of all of it: "Were controlled substances used to treat Sean Lynn — or were they used to restrain him?"

Mara: And the letter's answer to its own question is that a federal agency with jurisdiction over controlled substances is the appropriate body to find out.

Pip: The line between sedation and confinement — that's not a technicality. It's the whole question.

Mara: And when surveillance footage is gone and records are in dispute, the argument for independent review becomes harder to dismiss.